COMMUNIQUÉS West-GlobeNewswire

Shuttle Pharma Regains Compliance with Nasdaq Minimum Bid Price Requirement

28/08/2024 - 15:00

GAITHERSBURG, Md., Aug. 28, 2024 (GLOBE NEWSWIRE) -- Shuttle Pharmaceuticals Holdings, Inc. (Nasdaq: SHPH) (“Shuttle Pharma” or the “Company”), a discovery and development stage specialty pharmaceutical company focused [...]

AC Immune’s PI-2620 Tau-PET Diagnostic in Phase 3 Receives Fast Track Designation in Three Neurodegenerative Conditions

28/08/2024 - 15:00

AC Immune’s PI-2620 Tau-PET Diagnostic in Phase 3 Receives Fast Track Designation in Three Neurodegenerative Conditions PI-2620 is in Phase 3 development in Alzheimer’s disease by AC Immune’s partner, LMI This Fast [...]

Lord Jones® Live Resin Vapes and Ice Water Hash Pre-Rolls Now Available Across Canada

28/08/2024 - 15:00

TORONTO, Aug. 28, 2024 (GLOBE NEWSWIRE) -- Cronos Group Inc. (NASDAQ: CRON) (TSX: CRON) (“Cronos” or the “Company”) is expanding its portfolio for its Lord Jones ® brand with new innovations to bolster its lineup of [...]

HOOKIPA Pharma to Participate in the H.C. Wainwright 26th Annual Global Investment Conference

28/08/2024 - 14:57

NEW YORK and VIENNA, Aug. 28, 2024 (GLOBE NEWSWIRE) -- HOOKIPA Pharma Inc. (NASDAQ: HOOK, “HOOKIPA”, the “Company”), a company developing a new class of immunotherapeutics based on its proprietary arenavirus platform, [...]

SciSparc Grants Global Rights for Pain Therapy to Biotech Company in Agreement Worth up to $6 Million

28/08/2024 - 14:55

SciSparc would be entitled to receive consideration valued at $3 million in Polyrizon securities, as well as potential milestone fees of approximately $3 million in cash TEL AVIV, Israel, Aug. 28, 2024 (GLOBE NEWSWIRE [...]

Kane Biotech Announces Distribution Agreement with Qatar Datamation Systems for revyve™ Antimicrobial Wound Gel

28/08/2024 - 14:40

Company’s Second Distribution Agreement in Middle East WINNIPEG, Manitoba, Aug. 28, 2024 (GLOBE NEWSWIRE) -- Kane Biotech Inc. (TSX- V:KNE; OTCQB:KNBIF) (the “Company” or “Kane Biotech”) today announces that it has [...]

Sienna Senior Living Announces Closing of Common Share Offering for Gross Proceeds of Approximately $144 Million

28/08/2024 - 14:35

NOT FOR DISTRIBUTION TO THE U.S. NEWS WIRE SERVICES OR DISSEMINATION IN THE UNITED STATES MARKHAM, Ontario, Aug. 28, 2024 (GLOBE NEWSWIRE) -- Sienna Senior Living Inc. (“ Sienna ” or the “ Company ”) (TSX:SIA) today [...]

NurExone Reports Second Quarter 2024 Financial Results and Provides Corporate Update

28/08/2024 - 14:34

TORONTO and HAIFA, Israel, Aug. 28, 2024 (GLOBE NEWSWIRE) -- NurExone Biologic Inc. (TSXV: NRX) (OTCQB: NRXBF) (Germany: J90) (the “Company” or “NurExone”), a pioneering biopharmaceutical company developing regenerative [...]

Aprea Therapeutics to Present at the H.C. Wainwright Annual Global Investment Conference

28/08/2024 - 14:30

DOYLESTOWN, Pa., Aug. 28, 2024 (GLOBE NEWSWIRE) -- Aprea Therapeutics, Inc. (Nasdaq: APRE) (“Aprea” or the “Company”), a clinical stage biopharmaceutical company focused on precision oncology through synthetic lethality [...]

Ascendis Pharma to Report Second Quarter 2024 Financial Results and Provide Business Update on September 3, 2024

28/08/2024 - 14:30

COPENHAGEN, Denmark, Aug. 28, 2024 (GLOBE NEWSWIRE) -- Ascendis Pharma A/S (Nasdaq: ASND) today announced it will report second quarter 2024 financial results and provide a business update on Tuesday, September 3, 2024 [...]

IMUNON to Host R&D Day on September 18th

28/08/2024 - 14:30

R&D Discussion in New York City to Review IL-12’s Potential to Treat Ovarian Cancer Program Features Ovarian Cancer Thought Leaders, OVATION 2 Study Investigators, and Oncology Experts LAWRENCEVILLE, N.J., Aug. 28, [...]

Mestag Therapeutics Awarded Significant Grant from Innovate UK’s Prestigious Cancer Therapeutics Program to Accelerate the Path to the Clinic for MST-0300

28/08/2024 - 14:24

- Innovate UK, part of UK Research and Innovation, is investing £10 million in innovation projects to advance next-generation immunotherapies for cancer, of which £1.5 million has been awarded to Mestag - Bispecific [...]

Intra-Cellular Therapies to Present at Three Upcoming Investor Conferences

28/08/2024 - 14:00

NEW YORK, Aug. 28, 2024 (GLOBE NEWSWIRE) -- Intra-Cellular Therapies, Inc. (Nasdaq: ITCI), a biopharmaceutical company focused on the development and commercialization of therapeutics for central nervous system (CNS) [...]

Alignment Healthcare to Present at Baird Global Healthcare Conference

28/08/2024 - 14:00

ORANGE, Calif., Aug. 28, 2024 (GLOBE NEWSWIRE) -- Alignment Healthcare, Inc. (NASDAQ: ALHC), today announced that John Kao, founder and CEO, and Thomas Freeman, chief financial officer, will present at the Baird Global [...]

Pliant Therapeutics to Participate in Upcoming Investor Events

28/08/2024 - 14:00

SOUTH SAN FRANCISCO, Calif., Aug. 28, 2024 (GLOBE NEWSWIRE) -- Pliant Therapeutics, Inc. (Nasdaq: PLRX), a clinical-stage biotechnology company and leader in the discovery and development of novel therapeutics for the [...]

Avadel Pharmaceuticals to Present at Upcoming Investor Conferences

28/08/2024 - 14:00

DUBLIN, Ireland, Aug. 28, 2024 (GLOBE NEWSWIRE) -- Avadel Pharmaceuticals plc (Nasdaq: AVDL), a biopharmaceutical company focused on transforming medicines to transform lives, announced today that members of management [...]

Cabaletta Bio to Participate in Upcoming Investor Conferences in September

28/08/2024 - 14:00

PHILADELPHIA, Aug. 28, 2024 (GLOBE NEWSWIRE) -- Cabaletta Bio, Inc. (Nasdaq: CABA), a clinical-stage biotechnology company focused on developing and launching the first curative targeted cell therapies designed [...]

Keros Therapeutics Announces Participation at Upcoming Healthcare Conferences

28/08/2024 - 14:00

LEXINGTON, Mass., Aug. 28, 2024 (GLOBE NEWSWIRE) -- Keros Therapeutics, Inc. (“Keros” or the “Company”) (Nasdaq: KROS), a clinical-stage biopharmaceutical company focused on developing and commercializing novel [...]

X4 Pharmaceuticals to Participate in Upcoming September Investor Conferences

28/08/2024 - 14:00

BOSTON, Aug. 28, 2024 (GLOBE NEWSWIRE) -- X4 Pharmaceuticals (Nasdaq: XFOR), a company driven to improve the lives of people with rare diseases of the immune system, today announced that management will be participating [...]